Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
723 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 276
- Run by
- Fudan University
See details and how to joinNCT07492615 - No phaseTaking peopleA Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring
- Where
- Jinhua, Lishui
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- The Central Hospital of Lishui City
See details and how to joinNCT06792786 - 4. fázisNot yet taking people in KínaEsomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
- Where
- Lanzhou
- Életkor
- 18 év to 80 év
- People
- 120
- Run by
- LanZhou University
See details and how to joinNCT07312370 - 2. fázisTaking peopleKC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Beijing Konruns Pharmaceutical Co., Ltd.
See details and how to joinNCT07481058 - 2. fázisNot yet taking people in KínaEvaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT07486310 - 2. fázisTaking peoplePhase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07277439 - 2. fázisTaking peopleDisitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 124
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07474324 - 2. fázisTaking peopleCarilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Shandong Tumor Hospital
See details and how to joinNCT07320586 - No phaseTaking peopleDevelopment and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy
- Where
- Hangzhou, Jiaxing, Lishui
- Életkor
- 18 év and over
- People
- 5000
- Run by
- Zhejiang University
See details and how to joinNCT07104214 - No phaseTaking peopleThe Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy
- Where
- Hangzhou
- Életkor
- 18 év to 85 év
- People
- 400
- Run by
- Jichao Qin
See details and how to joinNCT07139418 - No phaseTaking peopleCombination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients
- Where
- Beijing, Hangzhou, Jinjiang, Lishui, Taizhou
- Életkor
- 18 év and over
- People
- 410
- Run by
- Zhejiang University
See details and how to joinNCT07175155 - 2. fázisTaking peopleEfficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 46
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07457528 - No phaseTaking peopleIntegrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)
- Where
- Wuhan
- People
- 1500
- Run by
- Shu Peng
See details and how to joinNCT07354295 - 3. fázisTaking peopleLaparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
- Where
- Qingdao
- Életkor
- 18 év to 80 év
- People
- 616
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT05871099 - 2. fázisTaking peopleA Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 28
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07455019 - 1. fázisTaking peopleStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- Where
- Beijing, Guangzhou, Hangzhou, Harbin, Hefei, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- I-Mab Biopharma US Limited
See details and how to joinNCT04900818 - 2. fázisTaking peopleEfficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Zekuan Xu
See details and how to joinNCT06461910 - No phaseCsak meghívásosEarly Postoperative Intervention in Gastric Cancer Patients
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 264
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07444099 - 2. fázisTaking peopleInduction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06452602 - 3. fázisTaking peopleA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Where
- Baise City, Beijing, Bengbu, Changchun, Changsha, Changzhi, Changzhou, Chengdu, Chongqing, Dezhou, Fuzhou, Guangdong, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou, Liuzhou, Luoyang, Mianyang, Nanchang, Nanjing, Qingdao, Shanghai, Shaoyang, Shenyang, Shijia Zhuang, Taiyuan, Tianjin, Ürümqi, Xiamen, Xining, Xuzhou, Yichang, Yinchuan, Zhengzhou
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06532006 · EU 2024-516633-12-00 - 2. fázisTaking peopleExploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
- Where
- Nanjing
- Életkor
- 70 év and over
- People
- 22
- Run by
- Jiangsu Cancer Institute & Hospital
See details and how to joinNCT07435454 - 2. fázisTaking peopleNeoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study
- Where
- Putian
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- The Affiliated Hospital of Putian University
See details and how to joinNCT07437898 - No phaseNot yet taking people in KínaAn Observational Study on Gastric Cancer in High-risk Individuals
- Where
- Tongling
- Életkor
- 40 év and over
- People
- 3000
- Run by
- Fudan University
See details and how to joinNCT07438418 - No phaseNot yet taking people in KínaClinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging
- Where
- Chongqing
- Életkor
- 18 év and over
- People
- 50
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07440212 - No phaseTaking peopleAn Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
- Where
- Tongling
- Életkor
- 40 év and over
- People
- 3000
- Run by
- Fudan University
See details and how to joinNCT06896370